Search for: "BRISTOW v. STATE" Results 21 - 40 of 84
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 May 2017, 2:55 am
|Fordham 25|Unwired Planet v Huawei: Is FRAND now a competition law free zone? [read post]
8 May 2017, 10:17 am
“Does it matter that most innovative activity, at least in the United States, is taking place in a small number of venture capital funded locations? [read post]
7 Dec 2016, 11:58 pm
 Paragraph [0003] of the Patent states that the invention is directed to chronic pain disorders. [read post]
18 Nov 2016, 12:44 am by John Collins
The case also provides a useful comparator for the England and Wales Court of Appeal’s judgment on 13 October 2016 in Warner-Lambert Company LLC v Generics (UK) Ltd (t/a Mylan) & Ors [2016] EWCA Civ 1006 (EWCA Judgment) (covered by Brian Cordery of Bristows  in ‘Pain and Plausibility – the Lyrica Appeal’), particularly with respect to how Australian and English law determine sufficiency and infringement of Swiss-style claims. [read post]
16 Nov 2016, 3:44 am
 Struck by this (and because her eyes glazed over that part of the decision), she asked Steven Willis (Bristows) to educate her and our readers about this aspect of the case. [read post]
22 Sep 2016, 5:32 pm
 Reaching consistency throughout the different states seems unlikely. [read post]
21 Sep 2016, 1:23 am by Dominic Adair
Any doubt on this issue is resolved by the CJEU decision in Solvay v Honeywell which provides a clear analogy. [read post]
20 Sep 2016, 4:29 am
| Good news and bad news for bio-pharmaceutical patenting in the United States | HP? [read post]
20 Sep 2016, 1:03 am by Vanessa Rieu
Moderator Dominic Adair (Partner, Bristows (UK)) led his panellists Fritz Reiter (Regulatory CMC Team Leader, Sandoz GmbH (AT)), Prof. [read post]
16 Sep 2016, 4:59 am
 Chaired by Mark Brown (Bristows), the panel featured Aimee Nisbet (Hearst Corporation), Eleonora Rosati (University of Southampton and IPKat), Nicholas Saunders (Brick Court Chambers) and Theo Savvides (Bristows). [read post]
29 Aug 2016, 11:03 am
 | Good news and bad news for bio-pharmaceutical patenting in the United States | HP? [read post]
1 Jun 2016, 1:28 am
Specifically, the Court noted that Recital 6 of the Directive states that “member states should also remain free to fix the provisions of procedure surrounding the registration, the revocation and invalidity of trade marks acquired by registration”. [read post]
25 Apr 2016, 5:00 am
Rachel Mumby and Claire Phipps-Jones (Bristows LLP) have come to the rescue and provide a summary of this year's proceedings. [read post]
24 Apr 2016, 4:59 pm by INFORRM
The was a discussion of the case on the Collyer Bristow website by Kate MacMillan. [read post]
5 Apr 2016, 6:32 am
Brian Cordery sets the stagefor second medical useAfter hearing the views of the IP judiciary, the Fordham audience was treated to a session devoted to second medical use claims, with Brian Cordery (Bristows LLP) moderating the panel. [read post]
17 Aug 2015, 2:29 am
 Dr Stevenson was an author of a paper relied on as a part of the state of the art. [read post]
22 Jun 2015, 9:24 am
.* Monarchy in the United States: validity is king, for patents at any rateThis is the first post from Jeremy on IPBC Global 2015 Intellectual Property Business Conference of San Francisco. [read post]
17 Jun 2015, 11:54 am
 Joe Cohen (Collyer Bristow LLP), who has long taken a keen interest in IP enforcement issues, has treated us to the following news, with some contextual explanation to accompany it. [read post]
19 May 2015, 4:09 pm by INFORRM
A case such as Smith v Trafford Housing Trust is less clear cut. [read post]